DYSLIPIDEMIA AND ATHEROGENIC RISK IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：1
|
作者：
Radillo, H. A. [1 ]
Batun, J. A. [1 ]
Hernandez, E. [1 ]
机构：
[1] Hosp Alta Especialidad Dr Gustavo A Rovirosa Pere, Villahermosa, Mexico
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5159
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0455
引用
收藏
页码：1062 / 1062
页数：1
相关论文
共 50 条
  • [1] Dyslipidaemia and atherogenic risk in patients with systemic lupus erythematosus
    Batun Garrido, Jose Antonio de Jesus
    Radillo Alba, Hugo Alberto
    Hernandez Nunez, Eufrates
    Olan, Francisco
    [J]. MEDICINA CLINICA, 2016, 147 (02): : 63 - 66
  • [2] Atherogenic risk in systemic lupus erythematosus
    Doria, A.
    Iaccarino, L.
    Ghirardello, A.
    Zampieri, S.
    Arienti, S.
    Todesco, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 22 - 23
  • [3] Dyslipidemia in systemic lupus erythematosus
    Szabo, Melinda Zsuzsanna
    Szodoray, Peter
    Kiss, Emese
    [J]. IMMUNOLOGIC RESEARCH, 2017, 65 (02) : 543 - 550
  • [4] Dyslipidemia in systemic lupus erythematosus
    Melinda Zsuzsanna Szabó
    Peter Szodoray
    Emese Kiss
    [J]. Immunologic Research, 2017, 65 : 543 - 550
  • [5] ANALYSIS OF DYSLIPIDEMIA IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Chen, A. S. H.
    Lee, J. H.
    Ya-Chiao, H.
    Yu, H. H.
    Wang, L. C.
    Lin, Y. T.
    Yang, Y. H.
    Chiang, B. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1778 - 1778
  • [6] Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus
    Olusi, Samuel O.
    George, Sunila
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2011, 7 : 75 - 80
  • [7] Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus
    Castro, Luisa Lima
    Duarte Lanna, Cristina Costa
    Pinho Ribeiro, Antonio Luiz
    Telles, Rosa Weiss
    [J]. CLINICAL RHEUMATOLOGY, 2018, 37 (10) : 2693 - 2698
  • [8] Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus
    Luísa Lima Castro
    Cristina Costa Duarte Lanna
    Antônio Luiz Pinho Ribeiro
    Rosa Weiss Telles
    [J]. Clinical Rheumatology, 2018, 37 : 2693 - 2698
  • [9] RISK OF SARCOPENIA IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
    Mayer, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S147 - S147
  • [10] Cardiovascular risk in patients with systemic lupus erythematosus
    Dobrota, V. Dermanovic
    Prkacin, I.
    Dobrota, S.
    Hrabac, P.
    Lukinovic-Skudar, V.
    [J]. CEREBROVASCULAR DISEASES, 2015, 39 : 35 - 35
12345